查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572040

抗菌素抗药性诊断市场：按产品类型、测试地点、设施类型划分 - 2025-2030 年全球预测

Antimicrobial Resistance Diagnostic Market by Product Type (Assays & Reagents, Diagnostic Tools), Testing Location (Laboratory Testing, Point-Of-Care Testing), Facility Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年抗生素抗药性诊断市值为45.3亿美元，预计到2024年将达到47.5亿美元，复合年增长率为6.14%，预计到2030年将达到68.8亿美元。

抗菌素抗药性 (AMR) 诊断市场包括旨在识别病原体抗药性模式和帮助治疗决策的技术和产品。这包括分子测试、免疫测量、快速诊断试剂套件等。抗药性感染疾病，这是一个重大的公共卫生挑战。 AMR 诊断对于指南适当的抗生素使用的临床实践和帮助追踪世界各地抗药性模式的公共卫生监测都很重要。该市场服务于各种最终用户，包括医院、诊所、实验室、学术机构和研究机构。重要的成长要素包括对抗菌素抗药性问题的认识提高、政府措施、诊断技术的进步以及减少抗生素滥用和过度使用的需要。照护现场诊断的快速发展以及人工智慧与诊断过程的整合正在为相关人员创造有希望的机会。然而，挑战依然存在，包括先进诊断设备的高成本、监管障碍以及基础设施投资的需求，特别是在低收入地区。关键的成长机会存在于开发适合资源有限环境的具有成本效益、易于使用的护理点设备。此外，开发能够快速提供全面抗药性光谱的下一代定序技术也具有潜力。公司应优先考虑满足全球医疗保健需求的快速、经济高效的诊断创新。加强公私伙伴关係可以加强研发工作并扩大市场范围。该市场潜力巨大，但经济限制、物流障碍以及部分地区渗透缓慢可能会阻碍成长。因此，重点关注创建意识提升计划来教育医疗保健提供者了解 AMR 诊断的好处并提高使用率可能具有战略意义。总体而言，建立伙伴关係、投资最尖端科技以及应对独特的区域挑战对于市场发展至关重要。

主要市场统计
基准年[2023] 45.3亿美元
预测年份 [2024] 47.5亿美元
预测年份 [2030] 68.8亿美元
复合年增长率（%） 6.14%

市场动态：快速发展的抗菌素抗药性诊断市场的关键市场洞察

供需的动态交互作用正在改变抗菌药物抗药性诊断市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 抗菌素抗药性日益普遍，导致对诊断解决方案的需求增加
    • 政府透过改进诊断措施对抗抗菌素抗药性的努力和资金
    • 提高医疗保健专业人员和公众对早期、准确的抗菌药物抗药性诊断重要性的认识
  • 市场限制因素
    • 与进阶诊断测试相关的高成本
  • 市场机会
    • 跨伙伴关係合作，利用综合诊断方法对抗抗菌素抗药性
    • 投资专注于抗菌药物抗药性诊断创新的新兴企业的机会
  • 市场挑战
    • 各地区标准化通讯协定和法规缺乏统一

波特的五力：引领抗菌素抗药性诊断市场的策略工具

波特的五力框架是了解抗菌素抗药性诊断市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解抗菌素抗药性诊断市场的外部影响

外部宏观环境因素在塑造抗菌素抗药性诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解抗菌药物抗药性诊断市场的竞争状况

抗菌素抗药性诊断市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵抗菌药物抗药性诊断市场供应商的绩效评估

FPNV定位矩阵是评估抗菌药物抗药性诊断市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了抗菌素抗药性诊断市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，抗菌素抗药性诊断市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 抗菌素抗药性的流行增加了对诊断解决方案的需求
      • 政府透过改进诊断措施对抗抗菌素抗药性的努力和资金
      • 医疗保健专业人员和公众越来越意识到早期准确诊断抗菌药物抗药性的重要性。
    • 抑制因素
      • 与进阶诊断测试相关的高成本
    • 机会
      • 跨部门伙伴关係，利用综合诊断方法对抗抗菌素抗药性
      • 投资专注于抗菌药物抗药性诊断创新的Start-Ups的机会
    • 任务
      • 不同地区的标准化通讯协定和法规缺乏统一
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章抗生素抗药性诊断市场：依产品类型

  • 测定和试剂
    • 生物感测器
    • 单株抗体
  • 诊断工具
    • 装置
    • 软体和服务

第七章按测试地点分類的抗菌素抗药性诊断市场

  • 临床检查
    • 恒温核酸增幅技术（INAAT）
    • 聚合酵素链锁反应(PCR)
  • 就地检验
    • 免疫检测
    • 微阵列

第八章按设施类型分類的抗生素抗药性诊断市场

  • 最终用户
    • 诊断实验室
    • 医院和诊所
  • 调查
    • CRO
    • 调查机构

第九章美洲抗菌素抗药性诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区抗菌药物抗药性诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲抗菌药物抗药性诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-2B5802CFEB38

The Antimicrobial Resistance Diagnostic Market was valued at USD 4.53 billion in 2023, expected to reach USD 4.75 billion in 2024, and is projected to grow at a CAGR of 6.14%, to USD 6.88 billion by 2030.

The antimicrobials resistance (AMR) diagnostics market encompasses technologies and products aimed at identifying resistance patterns in pathogens to inform treatment decisions. This includes molecular tests, immunoassays, and rapid diagnostic kits. The necessity for these diagnostics is underscored by the rising prevalence of drug-resistant infections, which pose substantial public health challenges. AMR diagnostics are critical in both clinical settings-where they guide appropriate antibiotic usage-and in public health surveillance, helping track resistance patterns worldwide. The market serves various end-users, including hospitals, clinics, laboratories, academic institutions, and research organizations. Significant growth factors include increasing awareness of AMR issues, governmental initiatives, advancements in diagnostic technologies, and the necessity to reduce misuse and overuse of antibiotics. The rapid development of point-of-care diagnostics and integration of AI in diagnostic processes present promising opportunities for stakeholders. However, challenges persist, including high costs of advanced diagnostic equipment, regulatory hurdles, and the need for investment in infrastructure, particularly in low-income regions. Key growth opportunities exist in developing cost-effective, easy-to-use point-of-care devices suitable for resource-limited settings. Moreover, there is potential in the development of next-generation sequencing technologies that can provide comprehensive resistance profiles swiftly. Businesses should prioritize innovation in rapid, cost-effective diagnostics, which align with global healthcare needs. Increasing collaboration between public and private sectors can enhance research and development efforts, thus expanding market reach. While the market offers robust potential, its growth can be stymied by logistical barriers and the slow adoption rate in some regions due to economic constraints. Therefore, focusing on educating healthcare providers about the benefits of AMR diagnostics and creating awareness programs to enhance adoption could be strategic. Overall, forging partnerships, investing in cutting-edge technology, and addressing region-specific challenges are pivotal for market advancement.

KEY MARKET STATISTICS
Base Year [2023] USD 4.53 billion
Estimated Year [2024] USD 4.75 billion
Forecast Year [2030] USD 6.88 billion
CAGR (%) 6.14%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antimicrobial Resistance Diagnostic Market

The Antimicrobial Resistance Diagnostic Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of antimicrobial resistance leading to a higher demand for diagnostic solutions
    • Government initiatives and funding to combat antimicrobial resistance through improved diagnostics
    • Growing awareness among healthcare professionals and public about the importance of early and accurate antimicrobial resistance diagnosis
  • Market Restraints
    • High cost associated with advanced diagnostic tests
  • Market Opportunities
    • Cross-sector partnerships to combat antimicrobial resistance using comprehensive diagnostic approaches
    • Investment opportunities in startups focused on antimicrobial resistance diagnostic innovations
  • Market Challenges
    • Lack of standardization protocol and regulatory harmonization across various region

Porter's Five Forces: A Strategic Tool for Navigating the Antimicrobial Resistance Diagnostic Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antimicrobial Resistance Diagnostic Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antimicrobial Resistance Diagnostic Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antimicrobial Resistance Diagnostic Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antimicrobial Resistance Diagnostic Market

A detailed market share analysis in the Antimicrobial Resistance Diagnostic Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antimicrobial Resistance Diagnostic Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antimicrobial Resistance Diagnostic Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antimicrobial Resistance Diagnostic Market

A strategic analysis of the Antimicrobial Resistance Diagnostic Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antimicrobial Resistance Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Beckman Coulter, Becton, Dickinson and Company, BioFire Diagnostics, bioMerieux, Bruker Corporation, Cardinal Health, Cepheid, GenMark Diagnostics, GSK plc, Hoffmann-La Roche, Hologic, Inc., Luminex Corporation, Merck & Co., Inc., OpGen, Qiagen, Siemens Healthineers, T2 Biosystems, and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Antimicrobial Resistance Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Assays & Reagents and Diagnostic Tools. The Assays & Reagents is further studied across Biosensors and Monoclonal Anitbodies. The Diagnostic Tools is further studied across Instruments and Software & Services.
  • Based on Testing Location, market is studied across Laboratory Testing and Point-Of-Care Testing. The Laboratory Testing is further studied across Isothermal Nucleic Acid Amplification Technology (INAAT) and Polymerase Chain Reaction (PCR). The Point-Of-Care Testing is further studied across Immunoassays and Microarray.
  • Based on Facility Type, market is studied across End User and Research. The End User is further studied across Diagnostic Laboratories and Hospitals And Clinics. The Research is further studied across CROs and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of antimicrobial resistance leading to a higher demand for diagnostic solutions
      • 5.1.1.2. Government initiatives and funding to combat antimicrobial resistance through improved diagnostics
      • 5.1.1.3. Growing awareness among healthcare professionals and public about the importance of early and accurate antimicrobial resistance diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with advanced diagnostic tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Cross-sector partnerships to combat antimicrobial resistance using comprehensive diagnostic approaches
      • 5.1.3.2. Investment opportunities in startups focused on antimicrobial resistance diagnostic innovations
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardization protocol and regulatory harmonization across various region
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antimicrobial Resistance Diagnostic Market, by Product Type

  • 6.1. Introduction
  • 6.2. Assays & Reagents
    • 6.2.1. Biosensors
    • 6.2.2. Monoclonal Anitbodies
  • 6.3. Diagnostic Tools
    • 6.3.1. Instruments
    • 6.3.2. Software & Services

7. Antimicrobial Resistance Diagnostic Market, by Testing Location

  • 7.1. Introduction
  • 7.2. Laboratory Testing
    • 7.2.1. Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.2.2. Polymerase Chain Reaction (PCR)
  • 7.3. Point-Of-Care Testing
    • 7.3.1. Immunoassays
    • 7.3.2. Microarray

8. Antimicrobial Resistance Diagnostic Market, by Facility Type

  • 8.1. Introduction
  • 8.2. End User
    • 8.2.1. Diagnostic Laboratories
    • 8.2.2. Hospitals And Clinics
  • 8.3. Research
    • 8.3.1. CROs
    • 8.3.2. Research Institutes

9. Americas Antimicrobial Resistance Diagnostic Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Antimicrobial Resistance Diagnostic Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Antimicrobial Resistance Diagnostic Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accelerate Diagnostics
  • 3. Beckman Coulter
  • 4. Becton, Dickinson and Company
  • 5. BioFire Diagnostics
  • 6. bioMerieux
  • 7. Bruker Corporation
  • 8. Cardinal Health
  • 9. Cepheid
  • 10. GenMark Diagnostics
  • 11. GSK plc
  • 12. Hoffmann-La Roche
  • 13. Hologic, Inc.
  • 14. Luminex Corporation
  • 15. Merck & Co., Inc.
  • 16. OpGen
  • 17. Qiagen
  • 18. Siemens Healthineers
  • 19. T2 Biosystems
  • 20. Thermo Fisher Scientific

LIST OF FIGURES

  • FIGURE 1. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY MONOCLONAL ANITBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 183. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 184. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 185. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 192. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 193. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 194. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 196. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 199. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 201. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 202. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 203. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 204. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 205. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 218. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 220. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 221. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 222. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 223. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 224. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 227. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 229. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 230. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 231. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 232. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 233. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 236. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 238. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 239. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 240. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 241. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 242. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 245. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 247. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 248. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 249. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 250. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 251. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 254. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 256. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 257. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 258. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 259. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 260. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 263. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 265. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 266. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 267. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 268. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 269. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 272. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 274. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 275. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 276. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 277. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 278. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 281. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 283. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
  • TABLE 284. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
  • TABLE 285. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 286. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
  • TABLE 287. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 290. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 292. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MAR